1 / 14

Effect of Rapid Clinic Follow-Up After Hospital Discharge on 30-Day Heart Failure Readmission

Effect of Rapid Clinic Follow-Up After Hospital Discharge on 30-Day Heart Failure Readmission. Lee Arcement, MD, MPH Dragana Lovre, MD. Summary. To assess the effect of a seven-site system-wide LSU HCSD quality improvement project (QIP)

taline
Download Presentation

Effect of Rapid Clinic Follow-Up After Hospital Discharge on 30-Day Heart Failure Readmission

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Effect of Rapid Clinic Follow-Up After Hospital Discharge on 30-Day Heart Failure Readmission Lee Arcement, MD, MPH Dragana Lovre, MD

  2. Summary • To assess the effect of a seven-site system-wide LSU HCSD quality improvement project (QIP) • To reduce 30-day Heart Failure (HF) readmissions by increasing % of discharged HF patients having post-discharge follow-up outpatient clinic visits to within two weeks of hospital discharge. • Informatics and analytical support required for the HF disease management program's HF readmission reduction QIP • Hypothesis: timely clinic follow-up after a HF-related inpatient discharge may reduce risk of short-term readmission.

  3. Aims/Methods/Timeline • 1: Background Analyses • 2: Analysis of Factors Related to Readmission • 3: Conduct interim reporting over the course of the QIP. • 4: Final Analysis of QIP

  4. Appropriate Lipid Therapy for Heart Failure Patients Lee Arcement, MD, MPH Phillip Paine, MD

  5. Summary • To assess the impact of a seven-site system-wide quality improvement project (QIP) • To improve appropriate lipid (statin) therapy for eligible patients in the LSU HCSD heart failure (HF) patient population. • Informatics and analytical support required for the HF program's lipid control QIP. • The QIP project will be directed to improving adherence to the current national guidelines for lipid control in heart failure patients.

  6. Four Possible Problems • Some HF patients may not be on statin therapy even though they are eligible for statin therapy and have non-optimal lipid control. • Some HF patients on statin therapy still have non-optimal lipid control, due to either inappropriate choice of statin or suboptimal dosing or other clinical factors. • Some HF patients on or off statin therapy may be poor candidates for statin therapy due to contraindications or intolerances. • Some HF patients on statin therapy may not have an indication for statin therapy

  7. Aims/Methods/Timeline • Aim 1: Background Analysis • Aim 2: Analysis of factors related to lipid control. • Aim 3: Analytical support for identifying methods for categorizing HF patients with regard for eligibility for statin therapy. • Aim 4: Conduct interim reporting over course of the QIP project. • Aim 5: Conduct final analysis on the effect of the QIP on lipid control levels within the HF patient population.

More Related